Viewing Study NCT02501603


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-05-29 @ 9:20 PM
Study NCT ID: NCT02501603
Status: COMPLETED
Last Update Posted: 2023-01-27
First Post: 2015-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer
Sponsor: Yonsei University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Cancer View
None Gastroesophageal Junction Cancer View
Keywords: